IMPL
Impel Neuropharma Inc
Price:  
0.24 
USD
Volume:  
858,521.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IMPL WACC - Weighted Average Cost of Capital

The WACC of Impel Neuropharma Inc (IMPL) is 5.7%.

The Cost of Equity of Impel Neuropharma Inc (IMPL) is 106.55%.
The Cost of Debt of Impel Neuropharma Inc (IMPL) is 5.00%.

Range Selected
Cost of equity 88.40% - 124.70% 106.55%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 5.3% - 6.0% 5.7%
WACC

IMPL WACC calculation

Category Low High
Long-term bond rate 4.2% 4.7%
Equity market risk premium 5.0% 6.0%
Adjusted beta 16.84 19.93
Additional risk adjustments 0.0% 0.5%
Cost of equity 88.40% 124.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 50.28 50.28
Cost of debt 5.00% 5.00%
After-tax WACC 5.3% 6.0%
Selected WACC 5.7%